A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma: results of the Cancer and Leukaemia Group B 90102.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples